Tapewire

Nasdaq · USD

CSTL

CASTLE BIOSCIENCES INC

Export transactions ↓
Tapewire entity
359
SEC CIK
0001447362
Parsed reports
578

Last 12 months

Inside the activity.

0 purchase rows · 214 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 2025010
Jan 202603
Feb 202603
Mar 2026026
Apr 2026014
May 2026028
Jun 2026015
Jul 2026036
Aug 2026044
Sep 2026015
Oct 202606

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 02, 2023 Filed Jun 6, 2023 20:42 UTC Exercise / conversionCommon Stock 3,825 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-23-000107 · wk-form4_1686084137.xml · nonDerivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,503

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 20:40 UTC Exercise / conversionRestricted Stock Units · Derivative 3,825 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000105 · wk-form4_1686084005.xml · derivative · entry 2

Cole G Bradley · CIK 0001337798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,825 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant on June 2, 2023.

F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant on June 2, 2023.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 20:40 UTC Exercise / conversionCommon Stock 3,825 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-23-000105 · wk-form4_1686084005.xml · nonDerivative · entry 1

Cole G Bradley · CIK 0001337798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,655

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 20:38 UTC Exercise / conversionRestricted Stock Units · Derivative 3,825 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000103 · wk-form4_1686083892.xml · derivative · entry 2

Goldberg Ellen · CIK 0001867100 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,825 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant on June 2, 2023.

F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant on June 2, 2023.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 20:38 UTC Exercise / conversionCommon Stock 3,825 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-23-000103 · wk-form4_1686083892.xml · nonDerivative · entry 1

Goldberg Ellen · CIK 0001867100 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,265

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 20:33 UTC Exercise / conversionRestricted Stock Units · Derivative 3,825 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000099 · wk-form4_1686083574.xml · derivative · entry 2

Olson Tiffany · CIK 0001442172 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,825 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant on June 2, 2023.

F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant on June 2, 2023.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 20:33 UTC Exercise / conversionCommon Stock 3,825 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-23-000099 · wk-form4_1686083574.xml · nonDerivative · entry 1

Olson Tiffany · CIK 0001442172 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,280

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
May 25, 2023 Filed May 30, 2023 21:55 UTC GrantRestricted Stock Units · Derivative 8,636 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000090 · wk-form4_1685483696.xml · derivative · entry 1

Harrison Miles · CIK 0001808228 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,636

Underlying: Common Stock · 8,636 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

F2 · derivative.expiration_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

Read SEC document
May 25, 2023 Filed May 30, 2023 21:57 UTC GrantRestricted Stock Units · Derivative 8,636 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000092 · wk-form4_1685483847.xml · derivative · entry 1

Olson Tiffany · CIK 0001442172 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,636

Underlying: Common Stock · 8,636 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

F2 · derivative.expiration_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

Read SEC document
May 25, 2023 Filed May 30, 2023 21:52 UTC GrantRestricted Stock Units · Derivative 8,636 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000088 · wk-form4_1685483536.xml · derivative · entry 1

Goldberg Ellen · CIK 0001867100 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,636

Underlying: Common Stock · 8,636 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

F2 · derivative.expiration_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

Read SEC document
May 25, 2023 Filed May 30, 2023 21:45 UTC
Caple KimDirector
GrantRestricted Stock Units · Derivative 8,636 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000084 · wk-form4_1685483116.xml · derivative · entry 1

Caple Kim · CIK 0001867184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,636

Underlying: Common Stock · 8,636 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

F2 · derivative.expiration_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

Read SEC document
May 25, 2023 Filed May 30, 2023 21:48 UTC GrantRestricted Stock Units · Derivative 8,636 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000086 · wk-form4_1685483321.xml · derivative · entry 1

Cole G Bradley · CIK 0001337798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,636

Underlying: Common Stock · 8,636 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

F2 · derivative.expiration_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

Read SEC document
May 25, 2023 Filed May 30, 2023 21:42 UTC GrantRestricted Stock Units · Derivative 8,636 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000082 · wk-form4_1685482924.xml · derivative · entry 1

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,636

Underlying: Common Stock · 8,636 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

F2 · derivative.expiration_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

Read SEC document
May 25, 2023 Filed May 30, 2023 21:38 UTC GrantRestricted Stock Units · Derivative 8,636 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000080 · wk-form4_1685482670.xml · derivative · entry 1

Aspinall Mara G. · CIK 0001623049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,636

Underlying: Common Stock · 8,636 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

F2 · derivative.expiration_date: The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024.

Read SEC document
May 16, 2023 Filed May 17, 2023 21:07 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 313 $22.82 $7,142.66
Disclosure

SEC source: 0001447362-23-000078 · wk-form4_1684357628.xml · nonDerivative · entry 14

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold

Disclosed balance after: 19,515

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F9 · price: This transaction was executed in multiple trades at prices ranging from $22.650 to $23.215, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Read SEC document
May 16, 2023 Filed May 17, 2023 21:07 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 313 $22.82 $7,142.66
Disclosure

SEC source: 0001447362-23-000078 · wk-form4_1684357628.xml · nonDerivative · entry 13

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold

Disclosed balance after: 19,521

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F9 · price: This transaction was executed in multiple trades at prices ranging from $22.650 to $23.215, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO John Derek Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Read SEC document
May 16, 2023 Filed May 17, 2023 21:07 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 313 $22.82 $7,142.66
Disclosure

SEC source: 0001447362-23-000078 · wk-form4_1684357628.xml · nonDerivative · entry 12

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold

Disclosed balance after: 19,521

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F9 · price: This transaction was executed in multiple trades at prices ranging from $22.650 to $23.215, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Read SEC document
May 16, 2023 Filed May 17, 2023 21:07 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 313 $22.82 $7,142.66
Disclosure

SEC source: 0001447362-23-000078 · wk-form4_1684357628.xml · nonDerivative · entry 11

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk

Disclosed balance after: 19,521

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F9 · price: This transaction was executed in multiple trades at prices ranging from $22.650 to $23.215, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk of which the Reporting Person is the trustee and his child is the beneficiary.

Read SEC document
May 16, 2023 Filed May 17, 2023 21:07 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 627 $22.82 $14,308.14
Disclosure

SEC source: 0001447362-23-000078 · wk-form4_1684357628.xml · nonDerivative · entry 10

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Derek Maetzold 2020 Irrevocable Trust

Disclosed balance after: 101,053

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F9 · price: This transaction was executed in multiple trades at prices ranging from $22.650 to $23.215, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4 · ownership.nature: Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.

Read SEC document
May 16, 2023 Filed May 17, 2023 21:07 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 627 $22.82 $14,308.14
Disclosure

SEC source: 0001447362-23-000078 · wk-form4_1684357628.xml · nonDerivative · entry 9

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold Descendants 2020 Trust

Disclosed balance after: 112,158

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F9 · price: This transaction was executed in multiple trades at prices ranging from $22.650 to $23.215, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.

Read SEC document
May 16, 2023 Filed May 17, 2023 21:07 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 1,254 $22.82 $28,616.28
Disclosure

SEC source: 0001447362-23-000078 · wk-form4_1684357628.xml · nonDerivative · entry 8

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,189

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F9 · price: This transaction was executed in multiple trades at prices ranging from $22.650 to $23.215, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 15, 2023 Filed May 17, 2023 21:07 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 384 $23.45 $9,003.65
Disclosure

SEC source: 0001447362-23-000078 · wk-form4_1684357628.xml · nonDerivative · entry 7

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold

Disclosed balance after: 19,828

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.830 to $23.620, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Read SEC document
May 15, 2023 Filed May 17, 2023 21:07 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 384 $23.45 $9,003.65
Disclosure

SEC source: 0001447362-23-000078 · wk-form4_1684357628.xml · nonDerivative · entry 6

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold

Disclosed balance after: 19,834

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.830 to $23.620, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO John Derek Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Read SEC document
May 15, 2023 Filed May 17, 2023 21:07 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 384 $23.45 $9,003.65
Disclosure

SEC source: 0001447362-23-000078 · wk-form4_1684357628.xml · nonDerivative · entry 5

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold

Disclosed balance after: 19,834

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.830 to $23.620, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Read SEC document
May 15, 2023 Filed May 17, 2023 21:07 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 384 $23.45 $9,003.65
Disclosure

SEC source: 0001447362-23-000078 · wk-form4_1684357628.xml · nonDerivative · entry 4

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk

Disclosed balance after: 19,834

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.830 to $23.620, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk of which the Reporting Person is the trustee and his child is the beneficiary.

Read SEC document
May 15, 2023 Filed May 17, 2023 21:07 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 769 $23.45 $18,030.74
Disclosure

SEC source: 0001447362-23-000078 · wk-form4_1684357628.xml · nonDerivative · entry 3

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Derek Maetzold 2020 Irrevocable Trust

Disclosed balance after: 101,680

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.830 to $23.620, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4 · ownership.nature: Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.

Read SEC document
May 15, 2023 Filed May 17, 2023 21:07 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 769 $23.45 $18,030.74
Disclosure

SEC source: 0001447362-23-000078 · wk-form4_1684357628.xml · nonDerivative · entry 2

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold Descendants 2020 Trust

Disclosed balance after: 112,785

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.830 to $23.620, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.

Read SEC document
May 15, 2023 Filed May 17, 2023 21:07 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 1,538 $23.45 $36,061.49
Disclosure

SEC source: 0001447362-23-000078 · wk-form4_1684357628.xml · nonDerivative · entry 1

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,443

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.830 to $23.620, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 10, 2023 Filed May 12, 2023 20:14 UTC Exercise / conversionRestricted Stock Units · Derivative 487 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000073 · wf-form4_168392242193165.xml · derivative · entry 2

Olson Tiffany · CIK 0001442172 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 487

Underlying: Common Stock · 487 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: On May 10, 2021, the Reporting Person was granted 1,460 RSUs, which vest in three equal annual installments beginning on May 10, 2022.

F2 · derivative.expiration_date: On May 10, 2021, the Reporting Person was granted 1,460 RSUs, which vest in three equal annual installments beginning on May 10, 2022.

Read SEC document
May 10, 2023 Filed May 12, 2023 20:14 UTC Exercise / conversionCommon Stock 487 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-23-000073 · wf-form4_168392242193165.xml · nonDerivative · entry 1

Olson Tiffany · CIK 0001442172 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,455

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
May 05, 2023 Filed May 8, 2023 20:26 UTC SaleCommon Stock 791 $21.80 $17,246.96
Disclosure

SEC source: 0001447362-23-000071 · wf-form4_168357756885543.xml · nonDerivative · entry 12

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Annette Bradbury Irrecovable Descendant's Trust

Disclosed balance after: 77,805

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022.

F8 · price: This transaction was executed in multiple trades at prices ranging from $21.570 to $22.145, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5 · ownership.nature: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.

Read SEC document
May 05, 2023 Filed May 8, 2023 20:26 UTC SaleCommon Stock 792 $21.80 $17,268.77
Disclosure

SEC source: 0001447362-23-000071 · wf-form4_168357756885543.xml · nonDerivative · entry 11

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Daniel Bradbury Irrecovable Descendant's Trust

Disclosed balance after: 77,780

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022.

F8 · price: This transaction was executed in multiple trades at prices ranging from $21.570 to $22.145, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4 · ownership.nature: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.

Read SEC document
May 05, 2023 Filed May 8, 2023 20:26 UTC SaleCommon Stock 2,376 $21.80 $51,806.30
Disclosure

SEC source: 0001447362-23-000071 · wf-form4_168357756885543.xml · nonDerivative · entry 10

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 139,539

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022.

F8 · price: This transaction was executed in multiple trades at prices ranging from $21.570 to $22.145, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.

Read SEC document
May 05, 2023 Filed May 8, 2023 20:26 UTC SaleCommon Stock 680 $21.12 $14,359.56
Disclosure

SEC source: 0001447362-23-000071 · wf-form4_168357756885543.xml · nonDerivative · entry 9

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Annette Bradbury Irrecovable Descendant's Trust

Disclosed balance after: 78,596

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022.

F7 · price: This transaction was executed in multiple trades at prices ranging from $20.570 to $21.565, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5 · ownership.nature: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.

Read SEC document
May 05, 2023 Filed May 8, 2023 20:26 UTC SaleCommon Stock 679 $21.12 $14,338.44
Disclosure

SEC source: 0001447362-23-000071 · wf-form4_168357756885543.xml · nonDerivative · entry 8

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Daniel Bradbury Irrecovable Descendant's Trust

Disclosed balance after: 78,572

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022.

F7 · price: This transaction was executed in multiple trades at prices ranging from $20.570 to $21.565, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4 · ownership.nature: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.

Read SEC document
May 05, 2023 Filed May 8, 2023 20:26 UTC SaleCommon Stock 2,039 $21.12 $43,057.56
Disclosure

SEC source: 0001447362-23-000071 · wf-form4_168357756885543.xml · nonDerivative · entry 7

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 141,915

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022.

F7 · price: This transaction was executed in multiple trades at prices ranging from $20.570 to $21.565, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:26 UTC SaleCommon Stock 2,396 $21.88 $52,422.08
Disclosure

SEC source: 0001447362-23-000071 · wf-form4_168357756885543.xml · nonDerivative · entry 6

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Annette Bradbury Irrecovable Descendant's Trust

Disclosed balance after: 79,276

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022.

F6 · price: This transaction was executed in multiple trades at prices ranging from $21.640 to $22.310, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5 · ownership.nature: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:26 UTC SaleCommon Stock 2,395 $21.88 $52,400.21
Disclosure

SEC source: 0001447362-23-000071 · wf-form4_168357756885543.xml · nonDerivative · entry 5

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Daniel Bradbury Irrecovable Descendant's Trust

Disclosed balance after: 79,251

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022.

F6 · price: This transaction was executed in multiple trades at prices ranging from $21.640 to $22.310, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4 · ownership.nature: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:26 UTC SaleCommon Stock 7,185 $21.88 $157,200.62
Disclosure

SEC source: 0001447362-23-000071 · wf-form4_168357756885543.xml · nonDerivative · entry 4

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 143,954

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022.

F6 · price: This transaction was executed in multiple trades at prices ranging from $21.640 to $22.310, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:26 UTC SaleCommon Stock 1,133 $21.29 $24,120.44
Disclosure

SEC source: 0001447362-23-000071 · wf-form4_168357756885543.xml · nonDerivative · entry 3

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Annette Bradbury Irrecovable Descendant's Trust

Disclosed balance after: 81,672

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.640 to $21.635, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5 · ownership.nature: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:26 UTC SaleCommon Stock 1,134 $21.29 $24,141.73
Disclosure

SEC source: 0001447362-23-000071 · wf-form4_168357756885543.xml · nonDerivative · entry 2

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Daniel Bradbury Irrecovable Descendant's Trust

Disclosed balance after: 81,646

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.640 to $21.635, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4 · ownership.nature: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:26 UTC SaleCommon Stock 3,400 $21.29 $72,382.60
Disclosure

SEC source: 0001447362-23-000071 · wf-form4_168357756885543.xml · nonDerivative · entry 1

BRADBURY DANIEL · CIK 0001236397 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 151,139

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.640 to $21.635, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:21 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 282 $21.94 $6,187.93
Disclosure

SEC source: 0001447362-23-000069 · wf-form4_168357729195445.xml · nonDerivative · entry 14

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold

Disclosed balance after: 20,212

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F9 · price: This transaction was executed in multiple trades at prices ranging from $21.815 to $22.170 inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:21 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 283 $21.94 $6,209.87
Disclosure

SEC source: 0001447362-23-000069 · wf-form4_168357729195445.xml · nonDerivative · entry 13

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold

Disclosed balance after: 20,218

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F9 · price: This transaction was executed in multiple trades at prices ranging from $21.815 to $22.170 inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO John Derek Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:21 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 283 $21.94 $6,209.87
Disclosure

SEC source: 0001447362-23-000069 · wf-form4_168357729195445.xml · nonDerivative · entry 12

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold

Disclosed balance after: 20,218

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F9 · price: This transaction was executed in multiple trades at prices ranging from $21.815 to $22.170 inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:21 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 283 $21.94 $6,209.87
Disclosure

SEC source: 0001447362-23-000069 · wf-form4_168357729195445.xml · nonDerivative · entry 11

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk

Disclosed balance after: 20,218

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F9 · price: This transaction was executed in multiple trades at prices ranging from $21.815 to $22.170 inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk of which the Reporting Person is the trustee and his child is the beneficiary.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:21 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 566 $21.94 $12,419.74
Disclosure

SEC source: 0001447362-23-000069 · wf-form4_168357729195445.xml · nonDerivative · entry 10

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Derek Maetzold 2020 Irrevocable Trust

Disclosed balance after: 102,449

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F9 · price: This transaction was executed in multiple trades at prices ranging from $21.815 to $22.170 inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4 · ownership.nature: Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:21 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 566 $21.94 $12,419.74
Disclosure

SEC source: 0001447362-23-000069 · wf-form4_168357729195445.xml · nonDerivative · entry 9

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold Descendants 2020 Trust

Disclosed balance after: 113,554

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F9 · price: This transaction was executed in multiple trades at prices ranging from $21.815 to $22.170 inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:21 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 1,132 $21.94 $24,839.48
Disclosure

SEC source: 0001447362-23-000069 · wf-form4_168357729195445.xml · nonDerivative · entry 8

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,981

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F9 · price: This transaction was executed in multiple trades at prices ranging from $21.815 to $22.170 inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:21 UTC
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
SaleCommon Stock 414 $21.43 $8,871.19
Disclosure

SEC source: 0001447362-23-000069 · wf-form4_168357729195445.xml · nonDerivative · entry 7

MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold

Disclosed balance after: 20,494

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 12, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.810 to $21.800, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold of which the Reporting Person is the trustee and his child is the beneficiary.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.